Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Contrast-induced Nephropathy
Interventions
OTHER

Exposure to CBCIN risk score

The computer-based contrast induced nephropathy (CBCIN) risk score and associated standard hydration strategy will be displayed on a monitor in front of the treating interventional cardiologist during the entirety of the PCI case. Since this scoring system and hydration strategy are both available in the peer-reviewed literature, clinical use of these data and implementation of a CIN-avoidance strategy is not experimental; however, the display of these data to interventional cardiologists is experimental. Based on exposure to these data, the treating interventional cardiologist may use the information as clinically appropriate (i.e. it is not the basis for clinical decisions).

Trial Locations (1)

60637

The University of Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Philips Healthcare

INDUSTRY

lead

University of Chicago

OTHER

NCT03305874 - Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization | Biotech Hunter | Biotech Hunter